Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Rohto Pharmaceutical (4527)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,064.0 -15.0    -0.49%
07:00:29 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 492,500
  • Bid/Ask: 3,056.0 / 3,064.0
  • Day's Range: 3,052.0 - 3,098.0
Type:  Equity
Market:  Japan
ISIN:  JP3982400008 
Rohto Pharmaceutical 3,064.0 -15.0 -0.49%

4527 Balance Sheet

 
Assess the latest Rohto Pharmaceutical balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 4527 Annual Report data, financial summaries and charts are available for Rohto Pharmaceutical investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 214196 207744 196136 190246
Cash and Short Term Investments 81877 79341 78080 79951
Cash - - - -
Cash & Equivalents 81877 79341 78080 79951
Short Term Investments - 2371 - 2260
Total Receivables, Net 73004 68329 59758 60656
Accounts Receivables - Trade, Net 73004 68329 59758 60656
Total Inventory 48496 48585 46554 41062
Prepaid Expenses - - - -
Other Current Assets, Total 10819 11489 11744 8577
Total Assets 342160 334957 318871 309677
Property/Plant/Equipment, Total - Net 68392 68356 66681 66182
Property/Plant/Equipment, Total - Gross - - - 172644
Accumulated Depreciation, Total - - - -106462
Goodwill, Net 2276 2372 2468 2564
Intangibles, Net 6851 6957 6999 6997
Long Term Investments 50443 49526 46586 32629
Note Receivable - Long Term 23747 23583 - 21327
Other Long Term Assets, Total 2 2 1 1
Other Assets, Total -13689 -8255 -1460 41
Total Current Liabilities 83633 82966 79138 80162
Accounts Payable 22415 22852 23701 18718
Payable/Accrued - - - -
Accrued Expenses 22786 23063 22284 24362
Notes Payable/Short Term Debt 4359 4171 4163 4177
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 34073 32880 28990 32905
Total Liabilities 96150 96159 92872 94600
Total Long Term Debt 5273 5823 6943 7516
Long Term Debt 5273 5823 6943 7516
Capital Lease Obligations - - - -
Deferred Income Tax - - - 1173
Minority Interest 5973 5859 5703 5508
Other Liabilities, Total -12727 -12299 -3075 -13575
Total Equity 246010 238798 225999 215077
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 6504 6504 6504 6504
Additional Paid-In Capital 5292 5292 5292 5292
Retained Earnings (Accumulated Deficit) 204620 197794 190290 184005
Treasury Stock - Common -4938 -4938 -4938 -4938
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 34532 34146 28851 24214
Total Liabilities & Shareholders' Equity 342160 334957 318871 309677
Total Common Shares Outstanding 228.14 228.14 228.14 228.14
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4527 Price Commentary

Write your thoughts about Rohto Pharmaceutical
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email